Due to the provisions of the Copyright Act and publisher's policies, we are unable to provide access to these articles in full-text format.

Callera GE, Touyz RM, Tostes RC, Yogi A, He Y, Malkinson S, and Schiffrin EL

Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src.

Hypertension

45(4):773-779, 2005.



Abbott KL, Archambault J, Xiao H, Nguyen BD, Roeder RG, Greenblatt J, Omichinski JG, Legault P
Interactions of the HIV-1 Tat and RAP74 Proteins with the RNA Polymerase II CTD Phosphatase FCP1.
Biochemistry,44(8):2716-2731, 2005.


Anderson SK, Dewar K, Goulet M-L, Leveque G, Makrigiannis AP

Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype

Genes Immun,

6(6):481-492, 2005.



Ao Z, Fowke KR, Cohen EA, and Yao X

Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import.

Retrovirology,

2(1):62, 2005.



Arnold R, Patzak IM, Neuhaus B, Vancauwenbergh S, Veillette A, Van Lint J, Kiefer F
Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.
Mol Cell Biol,
25(6):2364-2383, 2005.


Attie AD, Seidah NG

Dual regulation of the LDL receptor—Some clarity and new questions.

Cell Metab,

1(5):290-292, 2005.



Audet N, Paquin-Gobeil M, Landry-Paquet O, Schiller PW, Graciela P

Internalization and SRC activity regulate the time course of ERK activation by delta opioid receptor ligands.

J Biol Chem,

280(9):7808-7816, 2005.



Ballet S, Frycia A, Piron J, Chung NN, Schiller PW, Kosson P, Lipkowski AW, and Tourwé D

Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-d-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffold.

J Pept Res,

66(5):222-230, 2005.



Batsché É, Desroches J, Bilodeau S, Gauthier Y, and Drouin J,

Rb enhances 160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness.

J Biol Chem,

280(20):19746-19756, 2005.



Batsché E, Moschopoulos P, Desroches J, Bilodeau S, Drouin J 

Retinoblastoma and the related pocket protein P107 act as coactivators of neuroD1 to enhance gene transcription.

J Biol Chem,

280(16):16088-16095, 2005.



Beaucage P, Iglarz M, Servant M, Touyz RM, Moreau P
Position of Src tyrosine kinases in the interaction between angiotensin II and endothelin in in vivo vascular protein synthesis.
J Hypertens,23(2):329-335, 2005.


Béland M, Lohnes D

Chicken ovalbumin upstream promoter-transcription factor members repress Retinoic Acid-induced Cdx1 expression.

J Biol Chem,

280(14):13858-13862, 2005.



Bergeron A, Villemure M, Lazure C, Manjunath P

Isolation and characterization of the major proteins of ram seminal plasma.

Mol Reprod Dev,

71(4):461-470, 2005.



Bergeron E, Vincent MJ, Wickham L, Hamelin J, Basak A, Nichol ST, Chrétien M, Seidah NG

Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus.

Biochem Biophys Res Commun,

326(3):554-563, 2005.



Blanchet M, Sheppard R, Racine N, Ducharme A, Curnier D, Tardif JC, Sirois P, Lamoureux MC, de Champlain J, White M

Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.

Am Heart J,

149(5):e1-e7, 2005.



Bloch-Queyrat C, Fondanèche M-C, Chen R, Yin L, Relouzat F, Veillette A, Fischer A, Latour S
Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn.
J Exp Med,202(1):181-192, 2005.


Bouchard C, Dubuc G, Davignon J, Bernier L, Cohn JS

Post-transcriptional regulation of apoC-I synthesis and secretion in human HepG2 cells.

Atherosclerosis,

178(2):257-264, 2005.



Bourgault C, Davignon J, Fodor G, Gagne C, Gaudet D, Genest J, Lavoie MA, Leiter L, McPherson R, Senecal M, Marentette M, Sebaldt RJ
Statin therapy in Canadian patients with hypercholesterolemia: The Canadian Lipid Study-- Observational (CALIPSO).
Can J Cardiol,21(13):1187-1193, 2005.


Bouzeghrane F, Reinhardt DP, Reudelhuber TL, Thibault G
Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis.
Am J Physiol Heart Circ Physiol,289(3):H982-H991, 2005.


Brassard P, Amiri F, Schiffrin EL
Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Hypertension,46(3):598-606, 2005.


Braun BR, van Het Hoog M, d'Enfert C, Martchenko M, Dungan J, Kuo A, Inglis DO, Uhl MA, Hogues H, Berriman M, Lorenz M, Levitin A, Oberholzer U, Bachewich C, Harcus D, Marcil A, Dignard D, Iouk T, Zito R, Frangeul L, Tekaia F, Rutherford K, Wang E, Munro CA, Bates S, Gow NA, Hoyer LL, Köhler G, Morschhäuser J, Newport G, Znaidi S, Raymond M, Turcotte B, Sherlock G, Costanzo M, Ihmels J, Berman J, Sanglard D, Agabian N, Mitchell AP, Johnson AD, Whiteway M, Nantel A

A human-curated annotation of the Candida albicans genome.

PLoS Genet,

1(1):36-57, 2005.



Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, Pibarot P

Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis : Implications for diagnosis and treatment .

J Am Coll Cardiol

46(2):291-298, 2005.



Callera GE, Montezano ACI, Yogi A, Tostes RC, He Y, Schiffrin EL, Touyz RM

c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats.

Hypertension,

46(4):1032-1038, 2005.



Campos MM, Ongali B, Thibault G, Neugebauer W, and Couture R
Autoradiographic distribution and alterations of kinin B2 receptors in the brain and spinal cord of streptozotocin-diabetic rats.
Synapse,58(3):184-192, 2005.


Cardinal-David B, Guérin B, Guindon Y
Synthesis of tertiary and quaternary stereogenic centers: A diastereoselective tandem reaction sequence combining Mukaiyama and free radical-based allylation radical-based allylation.
J Org Chem,70(3):776-784, 2005.


Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, Nemer M

Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase- phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.

J Biol Chem,

280(6):4553-4567, 2005.



Charles MA, Suh H, Hjalt TA, Drouin J, Camper SA, Gage PJ

PITX genes are required for cell survival and Lhx3 activation.

Mol Endocrinol,

19(7):1893-1903, 2005.



Charron F, Tessier-Lavigne M
Novel brain wiring functions for classical morphogens: a role as graded positional cues in axon guidance.
Development,132(10):2251-2262, 2005.


Chen CF, Lohnes DL
Dominant-negative Retinoic Acid Receptors elicit epidermal defects through a non-canonical pathway.
J Biol Chem,280(4):3012-3021, 2005.


Chen H, Chung NN, Lemieux C, Zelent B, Vanderkooi JM, Gryczynski I, Wilkes BC, Schiller PW

[Aladan(3)]TIPP: A fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.

Biopolymers,

80(2-3):325-331, 2005.



Cohen LY, Bourbonnière M, Sabbagh L, Bouchard A, Chew T, Jeannequin P, Lazure C, Sékaly R-P

Notch1 antiapoptotic activity is abrogated by caspase cleavage in dying T lymphocytes.

Cell Death Differ,

12(3):243-254, 2005.



Costa-Mattioli M, Gobert D, Harding H, Herdy B, Azzi M, Bruno M, Bidinosti M, Ben Mamou C, Marcinkiewicz E, Yoshida M, Imataka H, Cuello AC, Seidah N, Sossin W, Lacaille J-C, Ron D, Nader K, Sonenberg N

Translational control of hippocampal synaptic plasticity and memory by the eIF2{alpha} kinase GCN2.

Nature,

436(7054):1166-1173, 2005.



Côté J-F, Motoyama AB, Bush JA, Vuori K

A novel and evolutionarily conserved PtdIns(3,4,5)P3-binding domain is necessary for DOCK180 signalling.

Nat Cell Biol,

7(8):797-807, 2005.



Coulombe B, Langelier M-F
Functional dissection of the catalytic mechanism of mammalian RNA polymerase II.
Biochem Cell Biol,83(4):497-504, 2005.


Cruzado MC, Risler NR, Miatello RM, Yao G, Schiffrin EL, Touyz RM
Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
Am J Hypertens,18(1):81-87, 2005.


D'Amour P, Brossard J-H, Rousseau L, Nguyen-Yamamoto L, Nassif E, Lazure C, Gauthier D, Lavigne JR, Zahradnik RJ
Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.
Kidney Int,

68(3):998-1007, 2005.


Danilovich N, Sairam MR
Targeting gonadotropin receptor genes: Reproductive biology, aging, and related health implications.
Endocrine,26(3):219-226, 2005.


Davignon J
Apolipoprotein E and atherosclerosis: Beyond lipid effect.
Arterioscler Thromb Vasc Biol,25(2):267-269, 2005.


Davignon J, Leiter LA
Ongoing clinical trials of the pleiotropic effects of statins.
Vascular Health and Risk Management,1(1):29-40, 2005.


Davignon J, Verma S, Anderson TJ
Pleiotropic effects of statins.
Expert Opinions Clinical Impact,1(5):9-12, 2005.


de Champlain J
Do angiotensin II antagonists provide benefits beyond blood pressure reduction?
Adv Ther,22(2):117-136, 2005.


de Champlain J

"L'hypertension artérielle est-elle une maladie fréquente?".

in : Questions et réponses : mon guide pour maîtriser l'hypertension artérielle. Édité par Denis Drouin, Alain Milot. Montréal : Société québécoise d'hypertension artérielle, 2005. P. 7



De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL

Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice. Evidence for a role in inflammation in angiotensin-induced vascular injury.

Arterioscler Thromb Vasc Biol,

25(10):2106-2113, 2005.



Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Schiffrin EL, Taddei S, Webb DJ
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.
J Hypertens,23(1):7-17, 2005.


Debrus S, Rahbani L, Marttila M, Delorme B, Paradis P, Nemer M
The zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of {alpha}1-adrenergic signaling.
Mol Cell Biol,25(19):8669-8682, 2005.


Dermaut B, Norga KK, Kania A, Verstreken P, Pan H, Zhou Y, Callaerts P, Bellen HJ
Aberrant lysosomal carbohydrate storage accompanies endocytic defects and neurodegeneration in Drosophila benchwarmer.
J Cell Biol,170(1):127-139, 2005.


Deschepper CF
The cardiac antihypertrophic effects of cyclic GMP-generating agents: An experimental framework for novel treatments of left ventricular remodeling.
Vascular Disease Prevention,2(2):151-157, 2005.


Deschepper CF

The many possible benefits of natriuretic peptides after myocardial infarction.

Hypertension,

46(2):271-272, 2005.



Desrosiers M-P, Kielczewska A, Loredo-Osti J-C, Adam SG, Makrigiannis AP, Lemieux S, Pham T, Lodoen MB, Morgan K, Lanier LL, Vidal SM

Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection.

Nat Genet.

37(6):593-599, 2005.



Dumais-Roy E, Béliveau L
Activité physique et impact sur la santé cardiovasculaire.
Les actualités du coeur,9(2):5-7, 2005.


EL Midaoui A, de Champlain J
Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes.
J Hypertens,23(3):581-588, 2005.


EL Midaoui A, Ongali B, Petcu M, Rodi D, de Champlain J, Neugebauer W, Couture R
Increases of spinal kinin receptor binding sites in two rat models of insulin resistance.
Peptides,26(8):1323-1330, 2005.


EL Midaoui A, Wu L, de Champlain J
Insulin, AGE and hypertension.
J Hypertens,23(8):1605, 2005.


Ferron M, Vacher J
Targeted expression of Cre recombinase in macrophages and osteoclasts in transgenic mice.
Genesis,41(3):138-145, 2005.


Filip K, Oleszczuk M, Wójcik J, Chung NN, Schiller PW, Pawlak D, Zieleniak A, Parciñska A, Witkowska E, Izdebski J
Cyclic enkephalin and dermorphin analogues containing a carbonyl bridge.
J Pept Sci,11(6):347-352, 2005.


Fontés G, Lajoix AD, Bergeron F, Cadel S, Prat A, Foulon T, Gross R, Dalle S, Le-Nguyen D, Tribillac F, Bataille D

Miniglucagon-generating endopeptidase, which processes glucagon into miniglucagon, is composed of NRD convertase and aminopeptidase B.

Endocrinology,

146(2):702-712, 2005.



Gao D, Kinouchi Y, Ito K, Zhao X
Neural networks for event extraction from time series: A back propagation algorithm approach.
Future Generation Computer Systems,21(7):1096-1105, 2005.


Garcia D, Barenbrug PJC, Pibarot P, Dekker ALAJ, van der Veen FH, Maessen JG, Dumesnil JG, Durand L-G

A ventricular-vascular coupling model in presence of aortic stenosis.

Am J Physiol Heart Circ Physiol,

288(4):H1874-H1884, 2005.



Garcia D, Kadem L, Pibarot P, Durand L-G
Mathematical modeling of coronary inflow in presence of aortic stenosis.
Comput Methods Biomech Biomed Engin,Suppl. 1:111-112, 2005.


Garcia D, Kadem L, Savéry D, Pibarot P, Durand L-G

Explicit analytical models for the aortic transvalvular pressure gradients.

in : Proceedings : 20th Canadian Congress of Applied Mechanics CANCAM 2005, May 30-June 2, 2005 = Comptes rendus : le 20e Congrès canadien de mécanique appliquée. Edited by M.Ostoja-Starzewski. Montréal : McGill University, 2005. P. 126-127.



Garcia D, Pibarot P, Durand L-G
Analytical modeling of the instantaneous pressure gradient across the aortic valve.
J Biomech,38(6):1303-1311, 2005.


Gaudreault SB, Blain J-F, Gratton J-P, Poirier J
A role for caveolin-1 in post-injury reactive neuronal plasticity.
J Neurochem,92(4):831-839, 2005.


Genest J

L'homme seul.

Saint-Laurent, Québec : Fidès,

2005.



Girouard H, de Champlain J
Acute and chronic effects of free radicals on {alpha}1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats.
J Hypertens,23(4):807-814, 2005.


Groupe de travail du Programme éducatif canadien sur l'hypertension, Touyz RM, de Champlain J, Larochelle P, Schiffrin E

Hypertension: Recommandations canadiennes 2005.

Les actualités du coeur,

9(2 Suppl.):1-8, 2005.



Grover A, Smith CE, Gregory M, Cyr DG, Sairam MR, Hermo L

Effects of FSH receptor deletion on epididymal tubules and sperm morphology, numbers, and motility.

Mol Reprod Dev,

72(2):135-144, 2005.



Guillemette B, Bataille AR, Gévry N, Adam M, Blanchette M, Robert F, Gaudreau L

Variant histone H2A.Z is globally localized to the promoters of inactive yeast genes and regulates nucleosome positioning.

PLos Biology,

3(12):2100-2110, 2005.



Guindon Y, Bencheqroun M, Bouzide A

Synthesis of postulated molecular probes: Stereoselective free-radical-mediated C-glycosylation in tandem with hydrogen transfer.

J Am Chem Soc,

127(2):554-558, 2005.



He X, He X, Dave VP, Zhang Y, Hua X, Nicolas E, Xu W, Roe BA, Kappes DJ
The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
Nature,433(7028):826-833, 2005.


He Y, Yao G, Savoia C, and Touyz RM

Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: Role of angiotensin II.

Circ Res,

96(2):207-215, 2005.



Hemmelgarn BR, McAlister FA, Myers MG, McKay DW, Bolli P, Abbott C, Schiffrin EL, Grover S, Honos G, Lebel M, Mann K, Wilson T, Penner B, Tremblay G, Tobe SW, Feldman RD
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - Blood pressure measurement, diagnosis and assessment of risk.
Can J Cardiol,21(8):645-656, 2005.


Houde M, Lamarre-Cliche M
Quels sont les risques de l'hypertension et les bénéfices du traitement?
in : Questions et réponses : mon guide pour maîtriser l'hypertension artérielle. Édité par Denis Drouin, Alain Milot. Montréal : Société québécoise d'hypertension artérielle, 2005. P. 31-32.


Huard K, Bourgeois P, Rhainds D, Falstrault L, Cohn JS, Brissette L

Apolipoproteins C-II and C-III inhibit selective uptake of low- and high-density lipoprotein cholesteryl esters in HepG2 cells.

Int J Biochem Cell Biol,

37(6):1308-1318, 2005.



Huber AB, Kania A, Tran TS, Gu C, De Marco Garcia N, Lieberam I, Johnson D, Jessell TM, Ginty DD, Kolodkin AL
Distinct roles for secreted semaphorin signaling in spinal motor axon guidance.
Neuron,48(6):949-964, 2005.


Jin W, Fuki IV, Seidah NG, Benjannet S, Glick JM, and Rader DJ,

Proprotein covertases are responsible for proteolysis and inactivation of endothelial lipase.

J Biol Chem,

280(44):36551-36559, 2005.



Jossart C, Coupal M, McNicoll N, Fournier A, Wilkes BC, De Léan A

Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: Development of a model.

Biochemistry,

44(7):2397-2408, 2005.



Kaczmarek K, Chung NN, Schiller PW

A novel cis-peptide bond motif inducing type VI {beta}-turn. Synthesis and biological evaluation of enkephalin and morphiceptin analogues conformationally restricted at the C-terminus.
in : Peptides 2004: Bridges Between Disciplines: Proceedings of the Third International and Twenty-Eighth European Peptide Symposium, September 5-10, 2004 - Prague, Czech Republic. Edited by Martin Flegel, Mati Fridkin, Chaim Gilon, Jirina Slaninova. Geneva, Switzerland : Kenes International, 2005. P. 868-869.


Kadem L, Dumesnil JG, Rieu R, Durand L-G, Garcia D, Pibarot P
Impact of systemic hypertension on the assessment of aortic stenosis.
Heart,91(3):354-361, 2005.


Kadem L, Knapp Y, Pibarot P, Bertrand E, Durand LG, Rieu R
A new experimental method for the determination of the effective oriffice area based on the acoustical term source.
in : Proceedings : 20th Canadian Congress of Applied Mechanics CANCAM 2005, May 30-June 2, 2005 = Comptes rendus : le 20e Congrès canadien de mécanique appliquée. Edited by M.Ostoja-Starzewski. Montréal : McGill University, 2005. P. 214-215.


Kadem L, Knapp Y, Pibarot P, Bertrand E, Garcia D, Durand LG, and Rieu R

A new experimental method for the determination of the effective orifice area based on the acoustical source term.

Experiments in Fluids,

39(6):1051-1060, 2005.



Kadem L, Rieu R, Garcia D, Durand LG, Pibarot P
Vortex dynamics and aortic valve closure.
Comput Methods Biomech Biomed Engin,Suppl. 1:157-158, 2005.


Karas M, Lacourcière Y, LeBlanc A-R, Nadeau R, Dubé B, Florescu M, Lamarre-Cliche M, Poirier L, Larochelle P, de Champlain J
Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.
J Hypertens,23(6):1251-1260, 2005.


Katarzyñska J, Chung NN, Schiller PW, Leplawy MT, Zabrocki J
Analogues of endomorphin-2 modified with 4-methyl-pseudoproline in position 2.
in : Peptides 2004: Bridges Between Disciplines: Proceedings of the Third International and Twenty-Eighth European Peptide Symposium, September 5-10, 2004 - Prague, Czech Republic. Edited by Martin Flegel, Mati Fridkin, Chaim Gilon, Jirina Slaninova. Geneva, Switzerland : Kenes International, 2005. P. 982-983.


Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, deChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NRC, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
Can J Cardiol,21(8):657-672, 2005.


Kruszynski R, Fichna J, do-Rego J-C, Chung NN, Schiller PW, Kosson P, Costentin J, Janecka A

Novel endomorphin-2 analogs with {mu}-opioid receptor antagonist activity.

J Pept Res,

66(3):125-131, 2005.



Lacombe M-J, Mercure C, Dikeakos JD, Reudelhuber TL

Modulation of secretory granule-targeting efficiency by cis and trans compounding of sorting signals.

J Biol Chem,

280(6):4803-4807, 2005.



Laganière J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguère V
Location analysis of estrogen receptor {alpha} target promoters reveals that FOXA1 defines a domain of the estrogen response.
Proc Natl Acad Sci U S A,102(33):11651-11656, 2005.


Lalanne F, Lambert G, Amar MJA, Chétiveaux M, Zaïr Y, Jarnoux A-L, Ouguerram K, Friburg J, Seidah NG, Brewer HB, Jr., Krempf M, and Costet P,

Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells.

J Lipid Res,

46(6):1312-1319, 2005.



Lamarre-Cliche M, de Champlain J, Lacourcière Y, Poirier L, Karas M, Larochelle P
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Am J Hypertens,18(1):56-64, 2005.


Langelier M-F, Baali D, Trinh V, Greenblatt J, Archambault J, Coulombe B
The highly conserved glutamic acid 791 of Rpb2 is involved in the binding of NTP and Mg(B) in the active center of human RNA polymerase II.
Nucleic Acids Res,33(8):2629-2639, 2005.


Laplante M-A, Wu R, Moreau P, de Champlain J
Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats.
Free Radic Biol Med,38(5):589-596, 2005.


Larochelle P
From the Canadian Hypertension Society.
Hypertension News: An Electronic Newsletter,Opus 7, 2005.


Larochelle P
Quelles sont les valeurs de la pression artérielle à retenir?
in : Questions et réponses : mon guide pour maîtriser l'hypertension artérielle. Édité par Denis Drouin, Alain Milot. Montréal : Société québécoise d'hypertension artérielle, 2005. P. 19-21.


Li D, Pickell L, Liu Y, Wu Q, Cohn JS, Rozen R
Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice.
Am J Clin Nutr,82(1):188-195, 2005.


Li W-C, Horb ME, Tosh D, Slack JMW

In vitro transdifferentiation of hepatoma cells into functional pancreatic cells.

Mech Dev,

122(6):835-847, 2005.



Llamas B, Contesse V, Guyonnet-Duperat V, Vaudry H, Mormède P, Moisan M-P
QTL mapping for traits associated with stress neuroendocrine reactivity in rats.
Mamm Genome,16(7):505-515, 2005.


Llamas B, Jiang Z, Rainville M-L, Picard S, Deschepper CF
Distinct QTLs are linked to cardiac left ventricular mass in a sex-specific manner in a normotensive inbred rat intercross.
Mamm Genome,16(9):700-711, 2005.


López de Cicco R, Bassi DE, Zucker S, Seidah NG, Klein-Szanto AJA
Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin.
Cancer Res,65(10):4162-4171, 2005.


Macpherson S, Akache B, Weber S, De Deken, X, Raymond M, Turcotte B
Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
Antimicrob Agents Chemother,49(5):1745-1752, 2005.


Makrigiannis AP, Patel D, Goulet M-L, Dewar K, Anderson SK

Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes.

Genes Immun,

6(2):71-83, 2005.



Maksumova L, Le HT, Muratkhodjaev F, Davidson D, Veillette A, Pallen CJ

Protein tyrosine phosphatase {alpha} regulates Fyn activity and Cbp/PAG phosphorylation in thymocyte lipid rafts.

J Immunol,

175(12):7947-7956, 2005.



Martens C, Bilodeau S, Maira M, Gauthier Y, Drouin J

Protein-Protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.

Mol Endocrinol,

19(4):885-897, 2005.



Morin S, Pozzulo G, Robitaille L, Cross J, and Nemer M

MEF2-dependent recruitment of the HAND1 transcription factor results in synergistic activation of target promoters.

J Biol Chem,

280(37):32272-32278, 2005.



Nagashima K, Lopez C, Donovan D, Ngai C, Fontanez N, Bensadoun A, Fruchart-Najib J, Holleran S, Cohn JS, Ramakrishnan R, Ginsberg HN

Effects of the PPAR{gamma} agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes.

J Clin Invest,

115(5):1323-1332, 2005



Neves MF, Amiri F, Virdis A, Diep QN, Schiffrin EL

Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.

Can J Physiol Pharmacol,

83(11):999-1006, 2005.



Nour N, Mayer G, Mort JS, Salvas A, Mbikay M, Morrison CJ, Overall CM, Seidah NG

The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.

Mol Biol Cell,

16(11):5215-5226, 2005.



Nudi M, Ouimette J-F, and Drouin J

Bone morphogenic protein (Smad)-mediated repression of Proopiomelanocortin transcription by interference with Pitx/Tpit activity.

Mol Endocrinol,

19(5):1329-1342, 2005.



Petcu M, Ongali B, EL Midaoui A, de Champlain J, Couture R

Effects of alpha-lipoic acid on kinin B(1) and B(2) receptor binding sites in the spinal cord of chronically angiotensin-treated rats.

Peptides,

26(8):1331-1338, 2005.



Pilorget A, Annabi B, Bouzeghrane F, Marvaldi J, Luis J, Béliveau R

Inhibition of angiogenic properties of brain endothelial cells by platelet-derived sphingosine-1-phosphate.

J Cereb Blood Flow Metab,

25(9):1171-1182, 2005.



Piñeyro G, Azzi M, deLéan A, Schiller PW, Bouvier M

Reciprocal regulation of agonist and inverse agonist signalling efficacy upon short-term treatment of the human delta-opioid receptor with an inverse agonist. 

Mol Pharmacol,

67(1):336-348, 2005.



Pladys P, Sennlaub F, Brault S, Checchin D, Lahaie I, Lê NLO, Bibeau K, Cambonie G, Abran D, Brochu M, Thibault G, Hardy P, Chemtob S, Nuyt AM

Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low protein diet in utero.

Am J Physiol Regul Integr Comp Physiol,

289(6):R1580-R1588, 2005.



Prakesch M, Grée D, Chandrasekhar S, Grée R
Synthesis of fluoro analogues of unsaturated fatty acids and corresponding acyclic metabolites.
Eur J Org Chem,(7):1221-1232, 2005.


Priceputu E, Rodrigue I, Chrobak P, Poudrier J, Mak TW, Hanna Z, Hu C, Kay DG, Jolicoeur P
The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1{beta}-converting enzyme-deficient or Bcl2-expressing transgenic mice.
J Virol,79(10):6377-6391, 2005.


Pu Q, Amiri F, Gannon P, Schiffrin EL
Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.
J Hypertens,23(2):401-409, 2005.


René C, Taulan M, Iral F, Doudement J, L'Honoré A, Gerbon C, Demaille J, Claustres M, Romey M-C
Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway.
Nucleic Acids Res,33(16):5271-5290, 2005.


Reudelhuber TL

The continuing saga of the AT2 receptor. A case of the good, the bad, and the innocuous.

Hypertension,

46(6):1261-1262, 2005.



Reudelhuber TL
The renin-angiotensin system: Peptides and enzymes beyond angiotensin II.
Curr Opin Nephrol Hypertens,14(2):155-159, 2005.


Roncagalli R, Taylor JER, Zhang S, Shi X, Chen R, Cruz-Munoz M-E, Yin L, Latour S, and Veillette A,

Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor.

Nat.Immunol.

6(10):1002-1010, 2005.



Roy DJ
Ethics in palliative care research.
in : Palliative Medicine : A Case-Based Manual. Edited by Neil MacDonald, Doreen Oneschuk, Neil Hagen, Derek Doyle. 2nd ed. Oxford, UK : Oxford University Press, 2005. P. 261-269.


Roy DJ
Late words to a dying man.
J Palliat Care,21(4):235-237, 2005.


Roy DJ
On questions no one can answer.
J Palliat Care,21(1):3-4, 2005.


Roy DJ
Songs of palliative care?
J Palliat Care,21(2):67-68, 2005.


Roy DJ
Palliative care without borders.
J Palliat Care,21(3):131-132, 2005.


Ruel IL, Couture P, Cohn JS, Lamarche B

Plasma metabolism of apoB-containing lipoproteins in patients with hepatic lipase deficiency.

Atherosclerosis,

180(2):355-366, 2005.



Ruel IL, Lamarche B, Mauger J-F, Badellino KO, Cohn JS, Marcil M, Couture P

Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.

Arterioscler Thromb Vasc Biol,

25(12):2600-2607, 2005.



Sairam MR
Introduction to the special issue: Current topics in gonadotropin biology and medine.
Endocrine,26(3):177-178, 2005.


Salvas A, Benjannet S, Reudelhuber TL, Chrétien M, and Seidah NG

Evidence for proprotein convertase activity in the endoplasmic reticulum/early Golgi.

FEBS Lett,

579(25):5621-5625, 2005.



Savoia C, Tabet F, Yao G, Schiffrin EL, Touyz RM
Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: Role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
J Hypertens,23(5):1037-1045, 2005.


Schiffrin EL

Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: Should this progress matter to patients?

Circulation,

112(11):1525-1526, 2005.



Schiffrin EL

Peroxisome proliferator-activated receptors and cardiovascular remodeling

Am J Physiol Heart Circ Physiol,

288(3):H1037-H1043, 2005.



Schiffrin EL

Vascular endothelin in hypertension.

Vasc Pharmacol,

43(1):19-29, 2005.



Schiffrin EL, Touyz RM
Calcium, magnesium, and oxidative stress in hyperaldosteronism.
Circulation,111(7):830-831, 2005.


Schiffrin EL

More evidence of cardiorenal protective effects of peroxisome proliferator-activated receptor activation.

Hypertension,

46(2):267-268, 2005.



Schiller PW

Current trends in the development of opioid analgesics.

AAPS Newsmagazine,

8(7):18-20, 2005.



Schiller PW

Opioid peptide-derived analgesics.

AAPS Journal,

7(3):E560-E565, 2005.



Schiller PW, Berezowska G, Weltrowska G, Chen H, Lemieux C, Chung NN
Type and location of fluorescent probes incorporated into the potent {mu}-opioid peptide [Dmt1]DALDA affect potency, receptor selectivity and intrinsic efficacy.
J Pept Res,65(6):556-563, 2005.


Shachter NS, Rabinowitz D, Stohl S, Conde-Knape K, Cohn JS, Deckelbaum RJ, Berglund L, Shea S

The common insertional polymorphism in the APOC1 promoter is associated with serum apolipoprotein C-I levels in Hispanic children.

Atherosclerosis,

179(2):387-393, 2005.



Shimoyama M, Kuwaki T, Nakamura A, Fukuda Y, Shimoyama N, Schiller PW, Szeto HH

Differential respiratory effects of [Dmt1]DALDA and morphine in mice.

Eur J Pharmacol,

511(2-3):199-206, 2005.



Siegfried G, Basak A, Prichett-Pejic W, Scamuffa N, Ma L, Benjannet S, Veinot JP, Calvo F, Seidah N, Khatib A-M

Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertases.

Oncogene,

24(46):6925-6935, 2005.



Simaan M, Bédard-Goulet S, Fessart D, Gratton J-P, and Laporte SA

Dissociation of {beta}-arrestin from internalized bradykinin B2 receptor is necessary for receptor recycling and resensitization.

Cell Signal,

17(9):1074-1083, 2005.



Souzeau E, Bélanger S, Picard S, Deschepper CF

Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood.

Am J Physiol Heart Circ Physiol,

289(2):H715-H721, 2005.



Stawowy P, Kallisch H, Borges Pereira Stawowy N, Stibenz D, Veinot JP, Gräfe M, Seidah NG, Chrétien M, Fleck E, Graf K

Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis.

Virchows Arch,

446(4):351-359, 2005.



Stawowy P, Meyborg H, Stibenz D, Stawowy NBP, Roser M, Thanabalasingam U, Veinot JP, Chrétien M, Seidah NG, Fleck E, Graf K

Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.

Circulation,

111(21):2820-2827, 2005.



Szeto HH, Schiller PW, Zhao K, Luo G

Fluorescent dyes alter intracellular targeting and function of cell-penetrating tetrapeptides.

FASEB J,

19(1):118-120, 2005.



Tabet F, Schiffrin EL, Touyz RM

Mitogen-activated protein kinase activation by hydrogen peroxide is mediated through tyrosine kinase-dependent, protein kinase C-independent pathways in vascular smooth muscle cells: upregulation in spontaneously hypertensive rats.

J Hypertens,

23(11):2005-2012, 2005.



Takeuchi JK, Mileikovskaia M, Koshiba-Takeuchi K, Heidt AB, Mori AD, Arruda EP, Gertsenstein M, Georges R, Davidson L, Mo R, Hui CC, Henkelman RM, Nemer M, Black BL, Nagy A, Bruneau BG

Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development.

Development,

132(10):2463-2474, 2005.



Temsah R and Nemer M,

GATA factors and transcriptional regulation of cardiac natriuretic peptide genes.

Regul Pept,

128(3):177-185, 2005.



Touyz RM
Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: Role of angiotensin II.
Exp Physiol,90(4):449-455, 2005.


Touyz RM
Molecular and cellular mechanisms in vascular injury in hypertension: Role of angiotensin II.
Curr Opin Nephrol Hypertens,14(2):125-131, 2005.


Touyz RM, Mercure C, He Y, Javeshghani D, Yao G, Callera GE, Yogi A, Lochard N, Reudelhuber TL

Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.

Hypertension,

45(4):530-537, 2005.



Touyz RM, Moreau P
Des changements aux habitudes de vie peuvent-ils prévenir ou atténuer l'hypertension?
in : Questions et réponses : mon guide pour maîtriser l'hypertension artérielle. Édité par Denis Drouin, Alain Milot. Montréal : Société québécoise d'hypertension artérielle, 2005. P. 35-37.


Touyz RM, Yao G, Schiffrin EL
Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells.
Can J Physiol Pharmacol,83(1):91-97, 2005.


Touyz RM, Yao G, Quinn MT, Pagano PJ, and Schiffrin EL,

p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: Role in NAD(P)H oxidase regulation by angiotensin II.

Arterioscler Thromb Vasc Biol,

25(3):512-518, 2005.



Tryoen-Tóth P, Décaillot FM, Filliol D, Befort K, Lazarus LH, Schiller PW, Schmidhammer H, Kieffer BL

Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors.

J Pharmacol Exp Ther,

313(1):410-421, 2005.



Tzimas GN, Chevet E, Jenna S, Nguyen DT, Khatib AM, Marcus V, Zhang Y, Chretien M, Seidah N, Metrakos P
Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastases.
BMC Cancer,5(1):149, 2005.


Vallette-Kasic S, Brue T, Pulichino A-M, Gueydan M, Barlier A, David M, Nicolino M, Malpuech G, Déchelotte P, Deal C, Van Vliet G, De Vroede M, Riepe FG, Partsch C-J, Sippell WG, Berberoglu M, Atasay B, de Zegher F, Beckers D, Kyllo J, Donohoue P, Fassnacht M, Hahner S, Allolio B, Noordam C, Dunkel L, Hero M, Pigeon B, Weill J, Yigit S, Brauner R, Heinrich JJ, Cummins E, Riddell C, Enjalbert A, Drouin J

Congenital isolated adrenocorticotropin deficiency: An underestimated cause of neonatal death, explained by TPIT mutations.

J Clin Endocrinol Metab,

90(3):1323-1331, 2005.



Van den Eynde I, Laus G, Schiller PW, Kosson P, Chung NN, Lipkowski AJ, Tourwé D

A new structural motif for {mu}-opioid antagonists.

J Med Chem,

48(10):3644-3648, 2005.



Van den Eynde I, Tourwé D, Kosson P, Lipkowski AJW, Chung NN, Schiller PW
Novel modifications of he Dmt-Tic pharmacophore provide new peptidomimetic {mu}-opioid antagonists.
in : Peptides 2004: Bridges Between Disciplines: Proceedings of the Third International and Twenty-Eighth European Peptide Symposium, September 5-10, 2004 - Prague, Czech Republic. Edited by Martin Flegel, Mati Fridkin, Chaim Gilon, Jirina Slaninova. Geneva, Switzerland : Kenes International, 2005. P. 958-959.


Vidric M, Suh W-K, Dianzani U, Mak TW, Watts TH
Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.
J Immunol,

175(11):7288-7296, 2005.


Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.

Virol J,

2(1):69, 2005.



Wang J, Paradis P, Aries A, Komati H, Lefebvre C, Wang H, Nemer M
Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4.
Mol Cell Biol,
25(22):9829-9844, 2005.


Weltrowska G, Lemieux C, Chung NN, and Schiller PW

Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists.

J Pept Res,

65(1):36-41, 2005.



Weltrowska G, Lemieux C, Chung NN, Schiller PW
Replacement of the Tyr1 hydroxyl group in a cyclic enkephalin analogue with various substituents results in potent opioid agonists.
in : Peptides 2004: Bridges Between Disciplines: Proceedings of the Third International and Twenty-Eighth European Peptide Symposium, September 5-10, 2004 - Prague, Czech Republic. Edited by Martin Flegel, Mati Fridkin, Chaim Gilon, Jirina Slaninova. Geneva, Switzerland : Kenes International, 2005. P. 978-979.


White PW, Faucher A-M, Massariol M-J, Welchner E, Rancourt J, Cartier M, Archambault J
Biphenylsulfonacetic Acid inhibitors of the human papillomavirus type 6 E1 helicase inhibit ATP hydrolysis by an allosteric mechanism involving tyrosine 486.
Antimicrob Agents Chemother,49(12):4834-4842, 2005.


Wickham L, Benjannet S, Marcinkiewicz E, Chretien M, Seidah NG
{beta}-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI3: Binding partners processed by furin.
J Neurochem,92(1):93-102, 2005.


Wiszniewska A, Kunce D, Chung NN, Schiller PW, and Izdebski J,

p-Nitrophenoxycarbonyl derivatives of Boc-protected diaminoalkanes in the synthesis of enkephalin peptidomimetics.

J Pept Sci,

11(9):579-583, 2005.



Witkowska R, Chung NN, Schiller PW, Zabrocki J
Synthesis and biological activity profile of new analogues of the cyclic opioid peptide H-Tyr-c[D-Cys-Gly-Phe(pNO2)-D-Cys]-NH2 containing (S)-{alpha}-hydroxymethylcysteine in place of cysteine.
J Pept Sci,
11(6):361-363, 2005.


Wu R, Laplante M-A, de Champlain J
Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats.
Hypertension,45(6):1139-1144, 2005.


Yokoyama H, Averill DB, Brosnihan KB, Smith RD, Schiffrin EL, Ferrario CM

Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.

Am J Hypertens,

18(7):922-929, 2005.



Zargham R, Thibault G
{alpha}8{beta}1 integrin expression in the rat carotid artery: Involvement in smooth muscle cell migration and neointima formation.
Cardiovasc Res,65(4):813-822, 2005.


Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T
Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy.
Kidney Int,
68(3):1048-1060, 2005.


Žigman M, Cayouette M, Charalambous C, Schleiffer A, Hoeller O, Dunican D, McCudden CR, Firnberg N, Barres BA, Siderovski DP, Knoblich JA

Mammalian inscuteable regulates spindle orientation and cell fate in the developing retina.

Neuron,

48(4):539-545, 2005.